Health and Human Services Secretary Alex Azar issued the following statement regarding Merck’s decision to substantially reduce prices for a number of drugs: “The President’s blueprint for lower drug prices is working, drug prices are coming down, and American patients are going to see the savings in their pocketbook. We welcome Merck’s decision to reduce ...
As part of the Trump administration’s efforts to lower drug prices and put American patients first, Health and Human Services Secretary Alex Azar requested today that FDA Commissioner Scott Gottlieb establish a working group to examine how to safely import prescription drugs from other countries in the event of a dramatic price increase for a ...
Hackers got into the Missouri health system’s network by a brute force attack on its remote desktop protocol, the same access used by the notorious SamSam ransomware variant. Powered by WPeMatico
American Hospital Association called on Congress to advance remote patient monitoring, reduce restrictions on tech, and include more hospitals in the Rural Health Care Program. Powered by WPeMatico
The American Medical Association and MedStar Health examined how physicians used Cerner and Epic electronic health records, and found a lot variability that could impact safety. Powered by WPeMatico
The agreement is to continue the public-private partnership to connect AI technology with genomic data to provide cancer therapy for veterans. Powered by WPeMatico
Below is a summary of the reunification process that the Departments of Health and Human Services (HHS), Homeland Security (DHS), and Justice (DOJ) are implementing for eligible children over 5 years of age who may have been separated from their parents. This document is intended to educate the public about the detailed interdepartmental reunification plan ...
Health and Human Services Secretary Alex Azar issued the following statement on FDA Commissioner Scott Gottlieb’s announcement of a Biosimilars Action Plan to aid the development of a market for biosimilars: “Increased competition is one of the key strategies President Trump outlined in the American Patients First blueprint to bring down prescription drug prices. Biologics ...
On Wednesday, Health and Human Services Secretary Alex Azar announced that Adam Boehler, currently Director of the Center for Medicare & Medicaid Innovation (CMMI), will also begin serving as Senior Advisor for Value-Based Transformation and Innovation. Boehler is the fourth individual Azar has appointed to serve as a senior advisor to the secretary overseeing one ...
